Abstract
We describe here in vitro activity for the combination of azithromycin or terbinafine and benzalkonium, cetrimide, cetylpyridinium, mupirocin, triclosan, or potassium permanganate. With the exception of potassium permanganate, the remaining antimicrobial drugs were active and had an MIC90 between 2 and 32 μg∕ml. The greatest synergism was observed for the combination of terbinafine and cetrimide (71.4%). In vivo experimental evaluations will clarify the potential of these drugs for the topical treatment of lesions caused by Pythium insidiosum.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.
MeSH terms
-
Anti-Infective Agents / pharmacology*
-
Azithromycin / pharmacology*
-
Benzalkonium Compounds / pharmacology
-
Cetrimonium
-
Cetrimonium Compounds / pharmacology
-
Cetylpyridinium / pharmacology
-
Drug Interactions
-
Drug Synergism
-
Drug Therapy, Combination
-
Microbial Sensitivity Tests
-
Mupirocin / pharmacology
-
Naphthalenes / pharmacology*
-
Potassium Permanganate / pharmacology
-
Pythium / drug effects*
-
Terbinafine
-
Triclosan / pharmacology
Substances
-
Anti-Infective Agents
-
Benzalkonium Compounds
-
Cetrimonium Compounds
-
Naphthalenes
-
Potassium Permanganate
-
Triclosan
-
Azithromycin
-
Cetylpyridinium
-
Mupirocin
-
Terbinafine
-
Cetrimonium